Inhibition of Serotonin Metabolic Enzyme UDP-Glucuronosyltransferases (UGT) 1A6 by Ochratoxins

被引:0
|
作者
Yuan, Yang [1 ]
Du, Peng [1 ]
Yang, Shumei [2 ]
机构
[1] Xinjiang Med Univ, Affiliated Hosp 2, Dept Neurosurg, Urumqi 830028, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 5, Dept Pharmaceut Preparat, Urumqi 830011, Peoples R China
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2017年 / 36卷 / 02期
关键词
enzyme inhibition; ochratoxins; serotonin; toxicity; UDP-glucuronosyltransferase (UGT) 1A6;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The exposure of human to ochratoxins is unavoidable, and toxicity of ochratoxins remains to severely threaten the health of human. The present study aims to investigate the influence of ochratoxins on the activity of important phase II drug-metabolizing enzymes (DMEs) UDP-glucuronosyltransferase (UGT) 1A6. The results showed that ochratoxin A and B exerted no influence on the activity of UGT1A6. However, ochratoxin C showed strong inhibition on the activity of UGT1A6. In silico docking study showed that higher binding free energy of ochratoxin C on the activity cavity of UGT1A6 mainly contributed to the stronger inhibition of ochratoxin C than ochratoxin A and B towards the activity of UGT1A6. Inhibition kinetic determination showed the noncompetitive inhibition of ochratoxin C on UGT1A6. The inhibition kinetic parameter (Ki) was calculated to be 2.5 mu M for the inhibition of ochratoxin C on UGT1A6. All these data will be beneficial for understanding the toxicity mechanism of ochratoxins. RESUMEN. La exposicion de los seres humanos a las ocratoxinas es inevitable y la toxicidad de las ocratoxinas sigue siendo una grave amenaza para la salud. El presente estudio tiene como objetivo investigar la influencia de ocratoxinas en la actividad de las enzimas que metabolizan la importante fase II de drogas (DME) UDP-glucuronosyltransferase (UGT) 1A6. Los resultados mostraron que la ocratoxina A y B no ejercen influencia alguna sobre la actividad de UGT1A6. Sin embargo, la ocratoxina C mostro una fuerte inhibicion de la actividad de UGT1A6. Un estudio de acoplamiento in silico mostro que el aumento de la energia libre de union de la ocratoxina C en la cavidad de la actividad de UGT1A6 contribuyo principalmente a la inhibicion mas fuerte de la ocratoxina C que la ocratoxina A y B hacia la actividad de UGT1A6. La cinetica de determinacion de la inhibicion mostro la inhibicion no competitiva de la ocratoxina C en UGT1A6. El parametro cinetico de inhibicion (Ki) se calculo que era 2,5 mu M para la inhibicion de la ocratoxina C en UGT1A6. Todos estos datos seran beneficiosos para la comprension del mecanismo de toxicidad de las ocratoxinas.
引用
收藏
页码:412 / 415
页数:4
相关论文
共 50 条
  • [21] The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases
    Soars, MG
    Ring, BJ
    Wrighton, SA
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) : 762 - 767
  • [22] New insights into the risk of phthalates: Inhibition of UDP-glucuronosyltransferases
    Liu, Xin
    Cao, Yun-Feng
    Ran, Rui-Xue
    Dong, Pei-Pei
    Gonzalez, Frank J.
    Wu, Xue
    Huang, Ting
    Chen, Jian-Xin
    Fu, Zhi-Wei
    Li, Rong-Shan
    Liu, Yong-Zhe
    Sun, Hong-Zhi
    Fang, Zhong-Ze
    CHEMOSPHERE, 2016, 144 : 1966 - 1972
  • [23] THE EXPRESSION OF UDP-GLUCURONOSYLTRANSFERASES OF THE UGT1 FAMILY IN HUMAN LIVER AND KIDNEY AND IN RESPONSE TO DRUGS
    SUTHERLAND, L
    EBNER, T
    BURCHELL, B
    BIOCHEMICAL PHARMACOLOGY, 1993, 45 (02) : 295 - 301
  • [24] Analysis of substrate specificities and tissue expression of rat UDP-glucuronosyltransferases UGT1A7 and UGT1A8
    Webb, LJ
    Miles, KK
    Auyeung, DJ
    Kessler, FK
    Ritter, JK
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) : 77 - 82
  • [25] Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?
    Lee, Paul
    Jones, Graham
    Seibela, Markus J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (04) : 337 - 340
  • [26] Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9
    Iyer, LV
    Ho, MN
    Shinn, WM
    Bradford, WW
    Tanga, MJ
    Nath, SS
    Green, CE
    TOXICOLOGICAL SCIENCES, 2003, 73 (01) : 36 - 43
  • [27] Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases
    Xin, Hong
    Qi, Xiao-Yi
    Wu, Jing-Jing
    Wang, Xin-Xin
    Li, Yan
    Hong, James Y.
    He, Wei
    Xu, Wei
    Ge, Guang-Bo
    Yang, Ling
    FOOD AND CHEMICAL TOXICOLOGY, 2016, 90 : 112 - 122
  • [28] Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7
    Antonio, L
    Xu, J
    Little, JM
    Burchell, B
    Magdalou, J
    Radominska-Pandya, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 411 (02) : 251 - 261
  • [29] Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3
    Huang, YH
    Galijatovic, A
    Nguyen, N
    Geske, D
    Beaton, D
    Green, J
    Green, M
    Peters, WH
    Tukey, RH
    PHARMACOGENETICS, 2002, 12 (04): : 287 - 297
  • [30] Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate
    King, CD
    Rios, GR
    Assouline, JA
    Tephly, TR
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 365 (01) : 156 - 162